MedPath

Pilot-study into the effectiveness of neurofeedback in the treatment of major depressive disorder (MDD).

Conditions
major depressive disorder, depression
Registration Number
NL-OMON26159
Lead Sponsor
niversity Maastricht (UM), Department of Psychiatry and Neuropsychology
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

1. MMD as a primary axis-1 diagnosis according to criteria of the DSM-IV-TR;

2. Informed consent.

Exclusion Criteria

1. History of braintrauma (commotio or contusio cerebri);

2. Current use of antipsychotics, moodstabilizers, benzodiazepines. the use of antidepressants is permitted if type and dosage are not changed during participation in the study;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Hamilton depression rating scale (17-item);<br /><br>2. Baseline frontal alpha-activity in resting EEG.<br>
Secondary Outcome Measures
NameTimeMethod
Quick Inventory Depression Scale- SelfRating (16 items).
© Copyright 2025. All Rights Reserved by MedPath